TY - JOUR
T1 - Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses
AU - Psarras, Stelios
AU - Volonaki, Eleni
AU - Skevaki, Chrysanthi L.
AU - Xatzipsalti, Maria
AU - Bossios, Apostolos
AU - Pratsinis, Harris
AU - Tsigkos, Stelios
AU - Gourgiotis, Dimitrios
AU - Constantopoulos, Andreas G.
AU - Papapetropoulos, Andreas
AU - Saxoni-Papageorgiou, Photini
AU - Papadopoulos, Nikolaos G.
N1 - Funding Information:
Disclosure of potential conflict of interest: P. Saxoni-Papageorgiou has received grants from Novartis and Schering-Plough. N. Papadopoulos has received grants from GlaxoSmithKline and AstraZeneca. The rest of the authors have no conflict of interest to disclose.
Funding Information:
Supported by the Hellenic Ministry of Education, Heraklitos Program, and the University of Athens.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2006/2
Y1 - 2006/2
N2 - Background: Human rhinoviruses, major precipitants of asthma exacerbations, infect the lower airway epithelium inducing inflammation. The possibility that viral infection may mediate angiogenesis, thus contributing to airway remodeling, has not been evaluated. Objective: To investigate whether epithelial infection with rhinovirus mediates angiogenesis in vitro, evaluate possible modulation by an atopic environment, and confirm angiogenic factor induction after in vivo rhinovirus infection. Methods: Bronchial epithelial cells were infected with rhinovirus and levels of vascular endothelial growth factor (VEGF), and angiopoietins were measured. The angiogenic effect of epithelial products was assessed in in vitro models of angiogenesis. PBMCs, obtained from patients with atopic asthma and normal controls, were exposed to rhinovirus; the ability of supernatants from these cultures differentially to affect rhinovirus-mediated epithelial VEGF production was evaluated. VEGF levels were measured in respiratory secretions from patients with asthma, before and during rhinovirus-induced exacerbations. Results: Epithelial infection with rhinovirus specifically stimulated mRNA expression and release of VEGF, but not angiopoietins, in a time-dependent and dose-dependent manner. Supernatants from these cultures were able to induce angiogenesis in vitro, significantly inhibited by a neutralizing anti-VEGF antibody. When bronchial cells were exposed to supernatants of rhinovirus-infected mononuclear cells from normal subjects or atopic patients with asthma, VEGF induction was significantly higher under the influence of the atopic environment. VEGF was elevated during rhinovirus-associated asthma exacerbations. Conclusion: Rhinovirus infection, a frequent event, induces VEGF production in bronchial epithelial cells and human airways, an effect enhanced in an atopic environment. Rhinovirus-associated, VEGF-mediated angiogenesis may contribute to airway remodeling in asthma.
AB - Background: Human rhinoviruses, major precipitants of asthma exacerbations, infect the lower airway epithelium inducing inflammation. The possibility that viral infection may mediate angiogenesis, thus contributing to airway remodeling, has not been evaluated. Objective: To investigate whether epithelial infection with rhinovirus mediates angiogenesis in vitro, evaluate possible modulation by an atopic environment, and confirm angiogenic factor induction after in vivo rhinovirus infection. Methods: Bronchial epithelial cells were infected with rhinovirus and levels of vascular endothelial growth factor (VEGF), and angiopoietins were measured. The angiogenic effect of epithelial products was assessed in in vitro models of angiogenesis. PBMCs, obtained from patients with atopic asthma and normal controls, were exposed to rhinovirus; the ability of supernatants from these cultures differentially to affect rhinovirus-mediated epithelial VEGF production was evaluated. VEGF levels were measured in respiratory secretions from patients with asthma, before and during rhinovirus-induced exacerbations. Results: Epithelial infection with rhinovirus specifically stimulated mRNA expression and release of VEGF, but not angiopoietins, in a time-dependent and dose-dependent manner. Supernatants from these cultures were able to induce angiogenesis in vitro, significantly inhibited by a neutralizing anti-VEGF antibody. When bronchial cells were exposed to supernatants of rhinovirus-infected mononuclear cells from normal subjects or atopic patients with asthma, VEGF induction was significantly higher under the influence of the atopic environment. VEGF was elevated during rhinovirus-associated asthma exacerbations. Conclusion: Rhinovirus infection, a frequent event, induces VEGF production in bronchial epithelial cells and human airways, an effect enhanced in an atopic environment. Rhinovirus-associated, VEGF-mediated angiogenesis may contribute to airway remodeling in asthma.
KW - Airway remodeling
KW - Asthma
KW - Bronchial epithelial cells
KW - Endothelial cells
KW - Viral infection
UR - http://www.scopus.com/inward/record.url?scp=31944439161&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31944439161&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2005.11.005
DO - 10.1016/j.jaci.2005.11.005
M3 - Article
C2 - 16461129
AN - SCOPUS:31944439161
SN - 0091-6749
VL - 117
SP - 291
EP - 297
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -